SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
31-Jan-24 4:56 PM View: | Cyclacel Pharmaceuticals, I... (CYCC) | 29-Jan-24 | Grant | 12,500 | -- | -- | 462% 2.71K to 15.21K | |
03-Jul-23 4:55 PM View: | Cyclacel Pharmaceuticals, I... (CYCC) | 30-Jun-23 | Grant | 21,219 | -- | -- | 109% 19.38K to 40.6K | |
16-Jun-22 8:32 PM View: | Infinity Pharmaceuticals, I... (INFI) | 16-Jun-22 | Grant | 30,919 | $0.68 | $20,994.00 | 100% 0 to 30.92K | |
16-Jun-22 4:11 PM View: | Cyclacel Pharmaceuticals, I... (CYCC) | 14-Jun-22 | Grant | 15,822 | -- | -- | 444% 3.56K to 19.38K | |
17-Jun-21 4:07 PM View: | Cyclacel Pharmaceuticals, I... (CYCC) | 15-Jun-21 | Grant | 3,561 | -- | -- | 100% 0 to 3.56K | |
16-Jan-20 3:55 PM View: | ArQule Inc. (ARQL) | 16-Jan-20 | Disposition (change in control) | 289,838 | $20.00 | $5,796,760.00 | (100%) 289.84K to 0 | |
20-Dec-19 4:08 PM View: | ArQule Inc. (ARQL) | 18-Dec-19 | Payment of Exercise | 178,495 | $20.11 | $3,589,530.00 | (38%) 468.33K to 289.84K | |
20-Dec-19 4:08 PM View: | ArQule Inc. (ARQL) | 18-Dec-19 | Option Exercise | 351,046 | $4.04 | $1,418,280.00 | 299% 117.29K to 468.33K | |
14-Jun-18 9:27 AM View: | ArQule Inc. (ARQL) | 13-Jun-18 | Payment of Exercise | 148,569 | $5.18 | $769,587.00 | (60%) 245.74K to 97.17K | 34% |
14-Jun-18 9:27 AM View: | ArQule Inc. (ARQL) | 13-Jun-18 | Option Exercise | 200,000 | $3.62 | $724,000.00 | 437% 45.74K to 245.74K | |
18-Jan-17 4:23 PM View: | ArQule Inc. (ARQL) | 14-Jan-17 | Payment of Exercise | 2,847 | $1.58 | $4,498.26 | (6%) 48.59K to 45.74K | (115%) |
19-Jan-16 10:15 AM View: | ArQule Inc. (ARQL) | 14-Jan-16 | Payment of Exercise | 2,847 | $1.86 | $5,295.42 | (6%) 51.43K to 48.59K | (82%) |
20-Jan-15 11:13 AM View: | ArQule Inc. (ARQL) | 14-Jan-15 | Payment of Exercise | 2,847 | $1.20 | $3,416.40 | (5%) 54.28K to 51.43K | (181%) |
16-Jan-14 2:48 PM View: | ArQule Inc. (ARQL) | 14-Jan-14 | Payment of Exercise | 2,847 | $2.36 | $6,718.92 | (5%) 57.13K to 54.28K | (43%) |
22-Jan-13 4:59 PM View: | ArQule Inc. (ARQL) | 18-Jan-13 | Payment of Exercise | 1,111 | $2.54 | $2,821.94 | (2%) 58.24K to 57.13K | (33%) |
15-Jan-13 4:44 PM View: | ArQule Inc. (ARQL) | 14-Jan-13 | Grant | 30,000 | -- | -- | 106% 28.24K to 58.24K | |
07-Jun-12 2:49 PM View: | ArQule Inc. (ARQL) | 06-Jun-12 | Market Purchase | 4,700 | $6.26 | $29,411.70 | 20% 23.54K to 28.24K | (46%) |
23-Jan-12 4:13 PM View: | ArQule Inc. (ARQL) | 20-Jan-12 | Payment of Exercise | 1,052 | $7.02 | $7,385.04 | (4%) 24.59K to 23.54K | 52% |
01-Sep-11 1:58 PM View: | ArQule Inc. (ARQL) | 31-Aug-11 | Market Purchase | 4,000 | $4.41 | $17,620.80 | 19% 20.59K to 24.59K | (23%) |
22-Jan-10 3:38 PM View: | ArQule Inc. (ARQL) | 20-Jan-10 | Payment of Exercise | 1,111 | $3.53 | $3,921.83 | 6% 19.48K to 20.59K | (5%) |
06-Feb-09 1:59 PM View: | ArQule Inc. (ARQL) | 20-Jan-09 | Grant | 11,700 | -- | -- | 117% 10.0K to 21.7K | |
11-Dec-08 11:57 AM View: | ArQule Inc. (ARQL) | 05-Dec-08 | Market Purchase | 10,000 | $3.39 | $33,947.00 | 100% 0 to 10.0K | (9%) |